O’Melveny Worldwide

Law360: 6 Firms Steer Medical Device Startup’s US$312M SPAC Merger

August 23, 2022


Medical device firm Biolog-id and special-purpose acquisition company Genesis Growth Tech Acquisition Corp. announced a merger agreement that would take Biolog-id public at an equity value of US$312 million. The merger is expected to close in the first quarter of 2023 and is still subject to shareholder approval and other closing conditions. Biolog-id, which is based in Bernay, France, builds medical devices that help health care professionals track red blood cells, plasma, platelets, and chemotherapy substances. O’Melveny & Myers LLP serves as legal counsel to Genesis Growth.

Read the full article here.